Real-World Observations in the Treatment of Aortic Stenosis With the Transfemoral SAPIEN 3 Transcatheter Heart Valve: Insights From China
This study demonstrates the safety and feasibility of SAPIEN 3 balloon-expandable THVs in TAVR for Chinese patients with severe AS, including those with BAV stenosis. These findings challenge historical relative contraindications for TAVR in BAV patients and highlight the potential of TAVR in diverse patient populations. Larger prospective studies with extended follow-ups are needed to refine patient selection and evaluate longer-term outcomes.
Authors
- Shouzheng Wang (ORCID: https://orcid.org/0000-0003-1856-7825)
- Shiguo Li (ORCID: https://orcid.org/0000-0002-1578-8844)
- Wenbin Ouyang (ORCID: https://orcid.org/0000-0003-1928-1765)
- Gejun Zhang (ORCID: https://orcid.org/0009-0005-3155-6057)
- Ziping Li (ORCID: https://orcid.org/0009-0003-6147-6619)
- Fengwen Zhang (ORCID: https://orcid.org/0000-0002-9272-5206)
- Peijian Wei
- Jie Dong (ORCID: https://orcid.org/0000-0001-7585-6637)
- Yiming Yan (ORCID: https://orcid.org/0009-0000-8538-9200)
- Junyi Wan
- Xiaxia Pan
- Donghui Xu
- Guangzhi Zhao
- Yongquan Xie
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Health and Family Planning Commission (CN)
Publication Details
- Journal
- Reviews in Cardiovascular Medicine
- Published
- 2025-05-22
- DOI
- https://doi.org/10.31083/rcm28800
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanming Project of Medicine in Shenzhen
- National Key Research and Development Program of China